Should RT-PCR be considered a gold standard in the diagnosis of COVID-19?

Dramé, Moustapha; Tabue Teguo, Maturin; Proye, Emeline; Hequet, Fanny; Hentzien, Maxime; Kanagaratnam, Lukshe; Godaert, Lidvine

Dramé, Moustapha; Tabue Teguo, Maturin; Proye, Emeline; Hequet, Fanny; Hentzien, Maxime; Kanagaratnam, Lukshe; Godaert, Lidvine.

Dramé M; Department of Clinical Research and Innovation, University Hospital of Martinique, Fort-de-France, Martinique, France.
Tabue Teguo M; Department of Geriatrics, University Hospital of Guadeloupe, Pointe-à-Pitre, Guadeloupe.
Proye E; Department of Geriatrics, General Hospital of Valenciennes, Valenciennes, France.
Hequet F; Department of Geriatrics, General Hospital of Valenciennes, Valenciennes, France.
Hentzien M; Department of Infectious Diseases, University Hospital of Reims, Reims, France.
Kanagaratnam L; Department of Clinical Research and Public Health, University Hospital of Reims, Reims, France.
Godaert L; Department of Geriatrics, General Hospital of Valenciennes, Valenciennes, France.

J Med Virol ; 92(11): 2312-2313, 2020 11.

Article in English | MEDLINE | ID: covidwho-209749

Subject(s)

COVID-19 Nucleic Acid Testing/standards; COVID-19/diagnosis; Reverse Transcriptase Polymerase Chain Reaction/standards; COVID-19 Serological Testing; Humans; SARS-CoV-2/genetics; Sensitivity and Specificity

Keywords

COVID-19; RT-PCR; diagnosis; gold standard; serology

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Reverse Transcriptase Polymerase Chain Reaction / COVID-19 Nucleic Acid Testing / COVID-19 Type of study: Diagnostic study Limits: Humans Language: English Journal: J Med Virol Year: 2020 Document Type: Article Affiliation country: Jmv.25996

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google